🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of the study is to investigate the upper gastro-intestinal...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2019-12-17
Trial ID
NCT04185051
Treatments Being Tested
A Randomized, Double-Blind, Placebo-Controlled, Crossover Design Study of C...
Status
Completed
Location
Yale University School of Medicine
Start Date
2016-06-30
Trial ID
NCT02800928
The purpose of this study is to evaluate how well aticaprant works as compa...
Status
Terminated
Location
UAB Huntsville Regional Medical Campus
Start Date
2024-06-26
Trial ID
NCT06514742
Treatments Being Tested
A Randomized, Double-Blind, Placebo-Controlled, Crossover Design Study of C...
Status
Completed
Location
Vince and Associates
Start Date
2015-12-31
Trial ID
NCT02641028
The purpose of this study is to evaluate the efficacy of aticaprant compare...
Status
Completed
Location
SW Biomedical Research LLC
Start Date
2022-06-22
Trial ID
NCT05455684
Treatments Being Tested
The purpose of this study is to assess how well aticaprant works compared t...
Status
Terminated
Location
Preferred Research Partners
Start Date
2024-09-19
Trial ID
NCT06635135
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of aticaprant compare...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2022-12-06
Trial ID
NCT05550532
Treatments Being Tested
The purpose of this study is to see how feasible it is to enroll participan...
Status
Recruiting
Location
CNS Network
Start Date
2026-03-02
Trial ID
NCT07615426
Treatments Being Tested
To measure the occupancy of brain kappa opioid receptors after single oral ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-12
Trial ID
NCT01232439
Treatments Being Tested
The purpose of this study is to assess the effects of aticaprant on QT/ QT ...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2022-05-30
Trial ID
NCT05387759
Treatments Being Tested